Bayer names Christoph Koenen chief medical officer

Bitget2026/10/01 06:33

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Bayer appointed Dr. Christoph Koenen as chief medical officer, effective Oct. 1, 2026.
Koenen will lead medical and scientific strategy in the pharma division.
He will retain his role as head of clinical development and operations at the pharmaceuticals unit.
Koenen has more than 25 years of global pharma industry experience, including senior roles at Bayer, Bristol Myers Squibb, Novo Nordisk, Boehringer Ingelheim, GSK.
He joined Bayer in 2022 from Otsuka Pharmaceutical, where he served as chief medical officer.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bayer AG published the original content used to generate this news brief on October 01, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Bayer names Christoph Koenen chief medical officer

You may also like

Crypto prices